In Ireland, the $800 million Kinsale facility deploying a first-of-its-kind hybrid continuous manufacturing platform for complex peptides was formally unveiled in September 2024, already producing tirzepatide, alongside a $2 billion total investment in the Limerick biologics site for biologic active ingredient production
Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss
Available at: DrV Aesthetics
GLP-1 (glucagon-like peptide-1) plays a key role in appetite regulation
Side-effects range from mild (nausea, injection-site discomfort) to serious and even life-threatening (allergic reactions, liver injury, systemic inflammatory response, endotoxin-related events)
10.1146/annurev.physiol.64.082201.154705